WS #996
The dominant signal in this window is a coordinated de-escalation in the Strait of Hormuz crisis, with Germany explicitly ruling out military involvement and the UK emphasizing diplomatic solutions. Multiple Reuters-sourced Bluesky posts confirm Germany's stance against participating in an Iran war or military efforts to secure the strait, while UK PM Starmer calls for a 'credible viable plan' with broad international partners. This aligns with earlier context of Starmer's de-escalatory tone, reducing immediate oil supply disruption risks and potentially easing energy market pressures. However, TotalEnergies' confirmation of 15% production cuts in Qatar, Iraq, and UAE due to conflict introduces a countervailing supply shock that could support oil prices despite the diplomatic developments. Corporate developments show mixed signals with specific ticker impacts. Eli Lilly reports positive Phase 3 results for its EBGLYSS eczema treatment in children, a regulatory catalyst for LLY. AirSculpt Technologies reports preliminary Q4 revenue miss ($33.4M vs $34.51M consensus) and intends to delay its annual report filing, negative for AIRS. Meta Platforms faces reports of potential 20%+ staff cuts (~16K jobs) to counter AI spending, though the company calls it 'speculative' and JPMorgan maintains Overweight rating, creating uncertainty for META. Additionally, Nebius signs an AI capacity deal with Meta for at least $12 billion, potentially offsetting cost concerns with growth investment. Crypto markets show bullish sentiment with BTC arb opportunities and ETH reclaiming key levels, while geopolitical developments remain highest significance for energy (oil prices) and broader market stability. The German and UK positions create a clear diplomatic front against military escalation, though the TotalEnergies production cuts maintain supply-side pressure.
Key developments
- Germany rules out military involvement in Iran war and Strait of Hormuz security
- TotalEnergies confirms 15% production cuts in Middle East due to conflict
- Eli Lilly reports positive Phase 3 results for pediatric eczema treatment
- AirSculpt Technologies misses Q4 revenue consensus and delays annual report
- Meta Platforms faces reports of 20%+ staff cuts amid AI spending